Last Wednesday, millions of older Americans covered by Medicare became eligible to get powerful weight-loss drugs for just $50 a month through a federal pilot program.
Dani Blum is a Health Reporter at The Times. Since joining in 2019, she has focused on critical health topics, including Covid-19 and pharmaceuticals like Ozempic, while also exploring themes in wellness and public health. Her work has been featured in numerous publications, including The New York Times, The Boston Globe, and The Sydney Morning Herald.















